subcutaneous formulation

January 25, 2021January 25, 2021

Canada Approves At-home Entyvio Injection for Crohn’s

Crohn's Disease, News

Health Canada has approved a self-injectable subcutaneous (under-the-skin) form of Entyvio (vedolizumab) as an at-home maintenance therapy for adults with Crohn’s disease (CD). The approval follows an earlier decision to ... Read more

May 11, 2020May 11, 2020

Entyvio At-home Injection Approved in Europe to Treat Adults With IBD

Crohn's Disease, News, Ulcerative colitis

The European Commission has approved a subcutaneous (under-the-skin) formulation of Entyvio (vedolizumab) for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). This ... Read more

April 5, 2019April 5, 2019

EMA Advances Under-the-skin Injection of Entyvio for Crohn’s and Ulcerative Colitis

News

The European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a new subcutaneous (under-the-skin) form of Entyvio (vedolizumab). Entyvio is a biologic agent developed by Millenium ... Read more